We were introduced in an article in Nikkan Kogyo Shimbun.
We were introduced in an article in Nikkei Biotech.
We received financing from Miyazaki Taiyo Capital Co., Ltd. (Headquarters: Miyazaki City, Miyazaki).
We raised 240 MM JPY during a second round of financing from Anniversaire Holdings Inc., Beyond Next Ventures Inc., Miyagin Venture Capital Inc., and SMBC Venture Capital Inc.
We have concluded a joint research agreement with Gene Techno Science Co., Ltd. (Headquarters: Chuo-ku, Tokyo, President: Masaharu Tani) to obtain an antibody that kills cancer cells…
Beyond Next Ventures Co., Ltd. underwrote a third-party allotment to raise 37.5 million yen in seed round funding.